UBT251
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
The United Bio-Technology (Hengqin) Co · Phase 3 · Active, not recruiting · Enrollment 600
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| UBT251 Injection 4.0 mg | Obesity or overweight | 4.0 mg | 52 | n/r | n/r |
| UBT251 Injection 6.0 mg | Obesity or overweight | 6.0 mg | 52 | n/r | n/r |
| UBT251 Injection Placebo 4.0 mg | Obesity or overweight | 4.0 mg | 52 | n/r | n/r |
| UBT251 Injection Placebo 6.0 mg | Obesity or overweight | 6.0 mg | 52 | n/r | n/r |